These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 15882662

  • 1. AMPD1 (C34T) polymorphism and clinical outcomes in patients undergoing myocardial revascularization.
    Andreassi MG, Botto N, Laghi-Pasini F, Manfredi S, Ghelarducci B, Farneti A, Solinas M, Biagini A, Picano E.
    Int J Cardiol; 2005 May 25; 101(2):191-5. PubMed ID: 15882662
    [Abstract] [Full Text] [Related]

  • 2. C677T polymorphism of the methylenetetrahydrofolate reductase gene is a risk factor of adverse events after coronary revascularization.
    Botto N, Andreassi MG, Rizza A, Berti S, Bevilacqua S, Federici C, Palmieri C, Glauber M, Biagini A.
    Int J Cardiol; 2004 Sep 25; 96(3):341-5. PubMed ID: 15301885
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial infarction patients.
    Collins RP, Palmer BR, Pilbrow AP, Frampton CM, Troughton RW, Yandle TG, Skelton L, Richards AM, Cameron VA.
    Am Heart J; 2006 Aug 25; 152(2):312-20. PubMed ID: 16875916
    [Abstract] [Full Text] [Related]

  • 4. Role of adenosine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure (influence on tumor necrosis factor-alpha level and outcome).
    Gastmann A, Sigusch HH, Henke A, Reinhardt D, Surber R, Gastmann O, Figulla HR.
    Am J Cardiol; 2004 May 15; 93(10):1260-4. PubMed ID: 15135700
    [Abstract] [Full Text] [Related]

  • 5. The role of a common adenosine monophosphate deaminase (AMPD)-1 polymorphism in outcomes of ischemic and nonischemic heart failure.
    Kolek MJ, Carlquist JF, Thaneemit-Chen S, Lazzeroni LC, Whiting BM, Horne BD, Muhlestein JB, Lavori P, Anderson JL.
    J Card Fail; 2005 Dec 15; 11(9):677-83. PubMed ID: 16360962
    [Abstract] [Full Text] [Related]

  • 6. The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure: a study in 686 consecutive patients.
    de Groote P, Lamblin N, Helbecque N, Mouquet F, Hermant X, Amouyel P, Dallongeville J, Bauters C.
    Am Heart J; 2006 Oct 15; 152(4):736-41. PubMed ID: 16996850
    [Abstract] [Full Text] [Related]

  • 7. Association between AMPD1 gene polymorphism and coagulation factors in patients with coronary heart disease.
    Agewall S, Norman B.
    Pathophysiol Haemost Thromb; 2006 Oct 15; 35(6):440-4. PubMed ID: 17565237
    [Abstract] [Full Text] [Related]

  • 8. Renin-angiotensin system and haemostasis gene polymorphisms and outcome after coronary artery bypass graft surgery.
    Völzke H, Kleine V, Robinson DM, Grimm R, Hertwig S, Schwahn C, Eckel L, Rettig R.
    Int J Cardiol; 2005 Jan 15; 98(1):133-9. PubMed ID: 15676177
    [Abstract] [Full Text] [Related]

  • 9. Surgical revascularization is associated with improved long-term outcomes compared with percutaneous stenting in most subgroups of patients with multivessel coronary artery disease: results from the Intermountain Heart Registry.
    Bair TL, Muhlestein JB, May HT, Meredith KG, Horne BD, Pearson RR, Li Q, Jensen KR, Anderson JL, Lappé DL.
    Circulation; 2007 Sep 11; 116(11 Suppl):I226-31. PubMed ID: 17846308
    [Abstract] [Full Text] [Related]

  • 10. Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents.
    Tamburino C, Angiolillo DJ, Capranzano P, Dimopoulos K, La Manna A, Barbagallo R, Tagliareni F, Mangiafico S, Guzman LA, Galassi AR, Bass TA.
    Catheter Cardiovasc Interv; 2008 Oct 01; 72(4):448-56. PubMed ID: 18814218
    [Abstract] [Full Text] [Related]

  • 11. Effect of adenosine monophosphate deaminase-1 C34T allele on the requirement for donor inotropic support and on the incidence of early graft dysfunction after cardiac transplantation.
    Taegtmeyer AB, Breen JB, Rogers P, Johnson PH, Smith J, Smolenski RT, Banner NR, Yacoub MH, Barton PJ.
    Am J Cardiol; 2009 May 15; 103(10):1457-62. PubMed ID: 19427446
    [Abstract] [Full Text] [Related]

  • 12. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
    Lee JY, Park DW, Yun SC, Lee SW, Kim YH, Lee CW, Hong MK, Park SW, Park SJ.
    J Am Coll Cardiol; 2009 Aug 25; 54(9):853-9. PubMed ID: 19695467
    [Abstract] [Full Text] [Related]

  • 13. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians.
    Rodés-Cabau J, Deblois J, Bertrand OF, Mohammadi S, Courtis J, Larose E, Dagenais F, Déry JP, Mathieu P, Rousseau M, Barbeau G, Baillot R, Gleeton O, Perron J, Nguyen CM, Roy L, Doyle D, De Larochellière R, Bogaty P, Voisine P.
    Circulation; 2008 Dec 02; 118(23):2374-81. PubMed ID: 19029471
    [Abstract] [Full Text] [Related]

  • 14. Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization.
    Das P, Moliterno DJ, Charnigo R, Mukherjee D, Steinhubl SR, Sneed JD, Booth DC, Ziada KM.
    J Invasive Cardiol; 2006 Sep 02; 18(9):405-8. PubMed ID: 16954577
    [Abstract] [Full Text] [Related]

  • 15. [Clinical characteristics, in-hospital outcomes and predictors of in-hospital mortality in patients with acute coronary syndromes without persistent ST-segment elevation assigned to early invasive treatment strategy].
    Szyguła-Jurkiewicz B, Wojnicz R, Trzeciak P, Niklewski T, Zembala M, Poloński L.
    Przegl Lek; 2005 Sep 02; 62(5):265-9. PubMed ID: 16334529
    [Abstract] [Full Text] [Related]

  • 16. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
    Halkin A, Selzer F, Marroquin O, Laskey W, Detre K, Cohen H.
    J Invasive Cardiol; 2006 Dec 02; 18(12):577-83. PubMed ID: 17197706
    [Abstract] [Full Text] [Related]

  • 17. Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II).
    Rodriguez AE, Baldi J, Fernández Pereira C, Navia J, Rodriguez Alemparte M, Delacasa A, Vigo F, Vogel D, O'Neill W, Palacios IF, ERACI II Investigators.
    J Am Coll Cardiol; 2005 Aug 16; 46(4):582-8. PubMed ID: 16098419
    [Abstract] [Full Text] [Related]

  • 18. The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation.
    Holmes DR, Kim LJ, Brooks MM, Kip KE, Schaff HV, Detre KM, Frye RL, Bypass Angioplasty Revascularization Investigation (BARI) Investigators.
    J Thorac Cardiovasc Surg; 2007 Jul 16; 134(1):38-46, 46.e1. PubMed ID: 17599484
    [Abstract] [Full Text] [Related]

  • 19. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.
    Javaid A, Steinberg DH, Buch AN, Corso PJ, Boyce SW, Pinto Slottow TL, Roy PK, Hill P, Okabe T, Torguson R, Smith KA, Xue Z, Gevorkian N, Suddath WO, Kent KM, Satler LF, Pichard AD, Waksman R.
    Circulation; 2007 Sep 11; 116(11 Suppl):I200-6. PubMed ID: 17846304
    [Abstract] [Full Text] [Related]

  • 20. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.
    Daemen J, Kuck KH, Macaya C, LeGrand V, Vrolix M, Carrie D, Sheiban I, Suttorp MJ, Vranckx P, Rademaker T, Goedhart D, Schuijer M, Wittebols K, Macours N, Stoll HP, Serruys PW, ARTS-II Investigators.
    J Am Coll Cardiol; 2008 Dec 09; 52(24):1957-67. PubMed ID: 19055986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.